InsidersTradesSigma
Track the CAREDX INC stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.6bn. The latest transaction was reported on 29 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: JOHN HANNA. All data is openly available.
Analysts rate CAREDX INC Buy (bullish), based on 6 analysts. Average price target: US$52.33.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
CAREDX INC es una empresa especializada en soluciones de diagnóstico para pacientes trasplantados. Se centra en el desarrollo de pruebas no invasivas para monitorizar la salud del injerto.